688399 硕世生物
交易中 04-28 13:56:52
资讯
新帖
简况
每周股票复盘：硕世生物（688399）2025年净亏损4107.85万元
证券之星 · 04-26 04:34
每周股票复盘：硕世生物（688399）2025年净亏损4107.85万元
图解硕世生物年报：第四季度单季净利润同比下降51.91%
证券之星 · 04-23
图解硕世生物年报：第四季度单季净利润同比下降51.91%
每周股票复盘：硕世生物（688399）股东户数增3.3%至8459户
证券之星 · 04-19
每周股票复盘：硕世生物（688399）股东户数增3.3%至8459户
股市必读：硕世生物（688399）今年截至4月3日累计跌幅已超20%
证券之星 · 04-07
股市必读：硕世生物（688399）今年截至4月3日累计跌幅已超20%
每周股票复盘：硕世生物（688399）股东户数增2.31%至8189户
证券之星 · 04-05
每周股票复盘：硕世生物（688399）股东户数增2.31%至8189户
每周股票复盘：硕世生物（688399）股东户数减少239户至8004户
证券之星 · 03-29
每周股票复盘：硕世生物（688399）股东户数减少239户至8004户
硕世生物净利连亏3年 2019年IPO募7亿招商证券保荐
中金财经 · 03-11
硕世生物净利连亏3年 2019年IPO募7亿招商证券保荐
硕世生物(688399.SH)2025年度归母净亏损3971.03万元
智通财经 · 02-27
硕世生物(688399.SH)2025年度归母净亏损3971.03万元
每周股票复盘：硕世生物（688399）股东户数增17.41%，户均持股下降
证券之星 · 01-18
每周股票复盘：硕世生物（688399）股东户数增17.41%，户均持股下降
硕世生物(688399)1月9日股东户数0.86万户，较上期增加17.41%
证券之星 · 01-12
硕世生物(688399)1月9日股东户数0.86万户，较上期增加17.41%
每周股票复盘：硕世生物（688399）拟拓展光伏电力业务
证券之星 · 2025-12-28
每周股票复盘：硕世生物（688399）拟拓展光伏电力业务
股市必读：12月24日硕世生物发生1笔大宗交易 成交金额373.38万元
证券之星 · 2025-12-25
股市必读：12月24日硕世生物发生1笔大宗交易 成交金额373.38万元
硕世生物（688399）披露拟增加发电业务经营范围，12月24日股价下跌0.43%
证券之星 · 2025-12-24
硕世生物（688399）披露拟增加发电业务经营范围，12月24日股价下跌0.43%
12月23日硕世生物现399.8万元大宗交易
证券之星 · 2025-12-23
12月23日硕世生物现399.8万元大宗交易
硕世生物最新公告：公司猴痘病毒核酸检测试剂盒被列入WHO应急使用清单
证券之星 · 2025-12-07
硕世生物最新公告：公司猴痘病毒核酸检测试剂盒被列入WHO应急使用清单
硕世生物（688399）披露实际控制人续签一致行动协议，12月05日股价下跌0.77%
证券之星 · 2025-12-05
硕世生物（688399）披露实际控制人续签一致行动协议，12月05日股价下跌0.77%
硕世生物(688399)11月20日股东户数0.77万户，较上期增加2.64%
证券之星 · 2025-12-03
硕世生物(688399)11月20日股东户数0.77万户，较上期增加2.64%
硕世生物：截至2025年11月10日，公司股东总数7512户
证券日报 · 2025-11-18
硕世生物：截至2025年11月10日，公司股东总数7512户
每周股票复盘：硕世生物（688399）召开2025年第二次临时股东大会并通过多项治理议案
证券之星 · 2025-11-16
每周股票复盘：硕世生物（688399）召开2025年第二次临时股东大会并通过多项治理议案
硕世生物（688399）披露2025年第二次临时股东大会决议公告，11月11日股价下跌1.65%
证券之星 · 2025-11-11
硕世生物（688399）披露2025年第二次临时股东大会决议公告，11月11日股价下跌1.65%
加载更多
公司概况
公司名称：
江苏硕世生物科技股份有限公司
所属行业：
医药制造业
上市日期：
2019-12-05
主营业务：
江苏硕世生物科技股份有限公司的主营业务是体外诊断试剂、配套检测仪器等体外诊断产品的研发、生产和销售。公司的主要产品是诊断试剂、诊断仪器、检测服务。
发行价格：
46.78
{"stockData":{"symbol":"688399","market":"SH","secType":"STK","nameCN":"硕世生物","latestPrice":61.04,"timestamp":1777355812000,"preClose":62.51,"halted":0,"volume":1084346,"delay":0,"changeRate":-0.0235,"floatShares":83871700,"shares":83871700,"eps":-0.9557,"marketStatus":"交易中","change":-1.47,"latestTime":"04-28 13:56:52","open":62.62,"high":63.63,"low":60.66,"amount":66998700,"amplitude":0.0475,"askPrice":61.21,"askSize":12,"bidPrice":61.05,"bidSize":4,"shortable":0,"etf":0,"ttmEps":-0.9557,"tradingStatus":2,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1777359600000},"marketStatusCode":2,"adr":0,"adjPreClose":62.51,"symbolType":"stock_kcb","openAndCloseTimeList":[[1777339800000,1777347000000],[1777352400000,1777359600000]],"highLimit":68.76,"lowLimit":56.26,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":83871721,"isCdr":false,"pbRate":1.79,"roa":"--","roe":"--","epsLYR":-0.49,"committee":-0.444444,"marketValue":5120000000,"turnoverRate":0.0129,"status":1,"floatMarketCap":5120000000},"requestUrl":"/m/hq/s/688399","defaultTab":"news","newsList":[{"id":"2630080283","title":"每周股票复盘：硕世生物（688399）2025年净亏损4107.85万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2630080283","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630080283?lang=zh_cn&edition=full","pubTime":"2026-04-26 04:34","pubTimestamp":1777149251,"startTime":"0","endTime":"0","summary":"截至2026年4月24日收盘，硕世生物报收于60.97元，较上周的57.0元上涨6.96%。本周，硕世生物4月24日盘中最高价报63.38元。硕世生物当前最新总市值51.14亿元，在医疗器械板块市值排名72/129，在两市A股市值排名3401/5200。来自业绩披露要点：硕世生物2025年归母净利润为-4107.85万元，同比下降1952.18%。来自公司公告汇总：硕世生物拟每10股转增4.8股，不派发现金红利。股本股东变化股东户数变动截至2026年4月10日，硕世生物股东户数为8459.0户，较3月31日增加270.0户，增幅3.3%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042600001930.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688399"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629029180","title":"图解硕世生物年报：第四季度单季净利润同比下降51.91%","url":"https://stock-news.laohu8.com/highlight/detail?id=2629029180","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629029180?lang=zh_cn&edition=full","pubTime":"2026-04-23 01:14","pubTimestamp":1776878079,"startTime":"0","endTime":"0","summary":"证券之星消息，硕世生物2025年年报显示，当年度公司主营收入3.39亿元，同比下降3.02%；归母净利润-4107.85万元，同比下降1952.18%；扣非净利润-1.03亿元，同比下降42.75%；其中2025年第四季度，公司单季度主营收入8153.96万元，同比上升0.02%；单季度归母净利润-4423.01万元，同比下降51.91%；单季度扣非净利润-6115.57万元，同比下降10.45%；负债率17.6%，投资收益697.95万元，财务费用227.43万元，毛利率63.16%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042300002434.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688399"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628756191","title":"每周股票复盘：硕世生物（688399）股东户数增3.3%至8459户","url":"https://stock-news.laohu8.com/highlight/detail?id=2628756191","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2628756191?lang=zh_cn&edition=full","pubTime":"2026-04-19 01:43","pubTimestamp":1776534188,"startTime":"0","endTime":"0","summary":"截至2026年4月17日收盘，硕世生物报收于57.0元，较上周的51.87元上涨9.89%。本周，硕世生物4月17日盘中最高价报57.61元。4月13日盘中最低价报49.2元。硕世生物当前最新总市值47.81亿元，在医疗器械板块市值排名80/129，在两市A股市值排名3584/5198。本周关注点股本股东变化：股东户数增3.3%至8459户股本股东变化股东户数变动截至2026年4月10日，公司股东户数为8459.0户，较3月31日增加270.0户，增幅3.3%；户均持股由1.02万股降至9915.0股，户均持股市值为51.43万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026041900000531.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688399","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625606677","title":"股市必读：硕世生物（688399）今年截至4月3日累计跌幅已超20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2625606677","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2625606677?lang=zh_cn&edition=full","pubTime":"2026-04-07 03:06","pubTimestamp":1775502374,"startTime":"0","endTime":"0","summary":"截至2026年4月3日收盘，硕世生物报收于51.12元，下跌2.94%，换手率0.87%，成交量7275.0手，成交额3727.03万元。交易信息汇总股价提醒4月3日硕世生物收盘报51.12元，跌2.94%，当日成交72.75万元。该股已连续2日下跌，当年累计跌幅21.18%。前10个交易日中，主力资金累计净流出5549.29万元，股价累计下跌10.79%；融资余额累计减少2117.81万元，融券余量累计减少1700股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040700002091.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688399"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625361996","title":"每周股票复盘：硕世生物（688399）股东户数增2.31%至8189户","url":"https://stock-news.laohu8.com/highlight/detail?id=2625361996","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2625361996?lang=zh_cn&edition=full","pubTime":"2026-04-05 03:00","pubTimestamp":1775329236,"startTime":"0","endTime":"0","summary":"截至2026年4月3日收盘，硕世生物报收于51.12元，较上周的55.6元下跌8.06%。本周，硕世生物3月30日盘中最高价报55.86元。本周关注点股本股东变化：股东户数较3月20日增加2.31%，达8189.0户股本股东变化：户均持股数量由1.05万股降至1.02万股股本股东变化：户均持股市值为53.77万元股本股东变化股东户数变动截至2026年3月31日，硕世生物股东户数为8189.0户，较3月20日增加185.0户，增幅2.31%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040500000808.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688399"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623133882","title":"每周股票复盘：硕世生物（688399）股东户数减少239户至8004户","url":"https://stock-news.laohu8.com/highlight/detail?id=2623133882","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2623133882?lang=zh_cn&edition=full","pubTime":"2026-03-29 03:01","pubTimestamp":1774724473,"startTime":"0","endTime":"0","summary":"截至2026年3月27日收盘，硕世生物报收于55.6元，较上周的58.69元下跌5.26%。本周，硕世生物3月23日盘中最高价报58.6元。3月27日盘中最低价报53.88元。硕世生物当前最新总市值46.63亿元，在医疗器械板块市值排名78/129，在两市A股市值排名3542/5191。户均持股数量由上期的1.02万股上升至1.05万股，户均持股市值为61.5万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032900000610.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688399","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618916596","title":"硕世生物净利连亏3年 2019年IPO募7亿招商证券保荐","url":"https://stock-news.laohu8.com/highlight/detail?id=2618916596","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618916596?lang=zh_cn&edition=full","pubTime":"2026-03-11 14:57","pubTimestamp":1773212223,"startTime":"0","endTime":"0","summary":"中国经济网北京3月11日讯 硕世生物 日前发布2025年度业绩快报公告，公司实现营业收入34,038.04万元，同比下降2.64%；实现归属于母公司所有者的净利润-3,971.03万元，同比亏损扩大3,770.86万元；实现归属于母公司所有者的扣除非经常性损益的净利润-10,383.16万元，同比亏损扩大3,199.45万元。 硕世生物首次公开发行股票的发行费用总额为7,286.12万元，其中，保荐及承销费用为5,493.46万元。","market":"hk","thumbnail":" http://caiji.3g.cnfol.com/colect/202603/11/20260311842746.png","type":0,"news_type":0,"thumbnails":[" http://caiji.3g.cnfol.com/colect/202603/11/20260311842746.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20260311/32060006.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK1147","06099","BK0239","BK0012","BK0183","600999","BK0276","BK0188","688399","BK0028","BK1564","BK0010"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614385074","title":"硕世生物(688399.SH)2025年度归母净亏损3971.03万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2614385074","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614385074?lang=zh_cn&edition=full","pubTime":"2026-02-27 23:40","pubTimestamp":1772206855,"startTime":"0","endTime":"0","summary":"智通财经APP讯，硕世生物(688399.SH)披露2025年度业绩快报，公司实现营业总收入3.4亿元，同比下降2.64%;实现归属于母公司所有者的净亏损3971.03万元;实现归属于母公司所有者的扣除非经常性损益的净亏损1.04亿元。报告期内，公司主营业务稳定发展，但受行业竞争加剧及医疗集采持续推进等影响，报告期内自产检测试剂产品增值税税率调整为13%，上述因素叠加导致分子诊断试剂的收入有所下降。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1408559.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["688399","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2604763925","title":"每周股票复盘：硕世生物（688399）股东户数增17.41%，户均持股下降","url":"https://stock-news.laohu8.com/highlight/detail?id=2604763925","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2604763925?lang=zh_cn&edition=full","pubTime":"2026-01-18 04:30","pubTimestamp":1768681825,"startTime":"0","endTime":"0","summary":"截至2026年1月16日收盘，硕世生物报收于77.7元，较上周的79.98元下跌2.85%。本周，硕世生物1月13日盘中最高价报83.38元，股价触及近一年最高点。本周关注点股本股东变化：截至2026年1月9日股东户数为8573.0户，较前期增加1271.0户，增幅17.41%股本股东变化：户均持股数量由上期1.15万股减少至9783.0股股本股东变化：户均持股市值为78.25万元股本股东变化股东户数变动截至2026年1月9日，硕世生物股东户数为8573.0户，较12月31日增加1271.0户，增幅17.41%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011800001374.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688399"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2602184365","title":"硕世生物(688399)1月9日股东户数0.86万户，较上期增加17.41%","url":"https://stock-news.laohu8.com/highlight/detail?id=2602184365","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602184365?lang=zh_cn&edition=full","pubTime":"2026-01-12 17:37","pubTimestamp":1768210673,"startTime":"0","endTime":"0","summary":"证券之星消息，近日硕世生物披露，截至2026年1月9日公司股东户数为8573.0户，较12月31日增加1271.0户，增幅为17.41%。在医疗器械行业个股中，硕世生物股东户数低于行业平均水平，截至1月9日，医疗器械行业平均股东户数为2.19万户。从股价来看，2025年12月31日至2026年1月9日，硕世生物区间涨幅为16.76%，在此期间股东户数增加1271.0户，增幅为17.41%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011200024342.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688399","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2594247965","title":"每周股票复盘：硕世生物（688399）拟拓展光伏电力业务","url":"https://stock-news.laohu8.com/highlight/detail?id=2594247965","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2594247965?lang=zh_cn&edition=full","pubTime":"2025-12-28 05:12","pubTimestamp":1766869933,"startTime":"0","endTime":"0","summary":"截至2025年12月26日收盘，硕世生物报收于70.91元，较上周的67.24元上涨5.46%。本周，硕世生物12月25日盘中最高价报73.49元。硕世生物当前最新总市值59.47亿元，在医疗器械板块市值排名59/127，在两市A股市值排名2951/5178。本周关注点公司公告汇总：硕世生物拟增加发电、输电、供（配）电业务，涉及园区光伏发电自用及售电。交易信息汇总12月24日硕世生物发生1笔大宗交易，成交金额373.38万元。12月23日硕世生物发生一笔399.8万元大宗交易。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122800001399.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688399","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2594401471","title":"股市必读：12月24日硕世生物发生1笔大宗交易 成交金额373.38万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2594401471","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2594401471?lang=zh_cn&edition=full","pubTime":"2025-12-25 03:51","pubTimestamp":1766605872,"startTime":"0","endTime":"0","summary":"截至2025年12月24日收盘，硕世生物报收于67.61元，下跌0.43%，换手率1.48%，成交量1.24万手，成交额8361.88万元。当日关注点来自交易信息汇总：12月24日主力与游资资金均呈净流入，合计达578.67万元，而散户资金净流出同等规模。来自公司公告汇总：硕世生物拟于2026年第一次临时股东会审议新增电力相关经营范围，涉及园区光伏发电自用及售电业务。大宗交易12月24日硕世生物发生1笔大宗交易，成交金额373.38万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122500001676.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688399","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2593408589","title":"硕世生物（688399）披露拟增加发电业务经营范围，12月24日股价下跌0.43%","url":"https://stock-news.laohu8.com/highlight/detail?id=2593408589","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593408589?lang=zh_cn&edition=full","pubTime":"2025-12-24 22:45","pubTimestamp":1766587518,"startTime":"0","endTime":"0","summary":"截至2025年12月24日收盘，硕世生物报收于67.61元，较前一交易日下跌0.43%，最新总市值为56.71亿元。该股当日开盘68.6元，最高68.6元，最低66.77元，成交额达8361.88万元，换手率为1.48%。根据公司近日发布的公告，江苏硕世生物科技股份有限公司拟增加公司经营范围，新增发电业务、输电业务、供（配）电业务，主要为园区内光伏发电设备所发电量自用及多余电量销售。该事项已提交2026年第一次临时股东会审议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122400041415.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688399","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2593496197","title":"12月23日硕世生物现399.8万元大宗交易","url":"https://stock-news.laohu8.com/highlight/detail?id=2593496197","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593496197?lang=zh_cn&edition=full","pubTime":"2025-12-23 17:57","pubTimestamp":1766483860,"startTime":"0","endTime":"0","summary":"证券之星消息，12月23日硕世生物发生大宗交易，交易数据如下：大宗交易成交价格63.46元，相对当日收盘价折价6.54%，成交6.3万股，成交金额399.8万元，买方营业部为平安证券股份有限公司山东分公司，卖方营业部为华西证券股份有限公司济南分公司。近三个月该股共发生2笔大宗交易，合计成交1010.0手，折价成交2笔。截至2025年12月23日收盘，硕世生物报收于67.9元，上涨1.65%，换手率1.94%，成交量1.63万手，成交额1.11亿元。该股最近90天内无机构评级。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122300029191.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688399","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2589876710","title":"硕世生物最新公告：公司猴痘病毒核酸检测试剂盒被列入WHO应急使用清单","url":"https://stock-news.laohu8.com/highlight/detail?id=2589876710","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2589876710?lang=zh_cn&edition=full","pubTime":"2025-12-07 15:40","pubTimestamp":1765093233,"startTime":"0","endTime":"0","summary":"硕世生物(688399.SH)公告称，公司产品猴痘病毒核酸检测试剂盒（荧光PCR法）于近日被列入世界卫生组织（WHO）应急使用清单。该产品批准日期为2025年12月3日，采购期限为1年。公司表示，被列入WHO EUL可为WHO成员国和各意向采购方提供采购依据，对公司产品在相关海外市场的推广和销售起到推动作用。但实际销售情况受海外市场政策环境、检测需求、同类产品竞争等因素影响，产品销售规模存在不确定性。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120700002594.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688399","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2589813852","title":"硕世生物（688399）披露实际控制人续签一致行动协议，12月05日股价下跌0.77%","url":"https://stock-news.laohu8.com/highlight/detail?id=2589813852","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2589813852?lang=zh_cn&edition=full","pubTime":"2025-12-05 22:23","pubTimestamp":1764944605,"startTime":"0","endTime":"0","summary":"截至2025年12月5日收盘，硕世生物报收于67.98元，较前一交易日下跌0.77%，最新总市值为57.02亿元。该股当日开盘68.94元，最高68.94元，最低67.1元，成交额达5547.08万元，换手率为0.98%。公司近日发布公告称，实际控制人房永生、梁锡林、王国强于2025年12月5日续签《一致行动协议》，协议自签署日起生效，有效期十二个月。本次续签旨在保持公司经营的连续性与稳定性，确保决策一致性。续签后公司实际控制权未发生变化，不存在损害中小投资者利益的情形。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120500040463.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688399"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2588014624","title":"硕世生物(688399)11月20日股东户数0.77万户，较上期增加2.64%","url":"https://stock-news.laohu8.com/highlight/detail?id=2588014624","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588014624?lang=zh_cn&edition=full","pubTime":"2025-12-03 17:28","pubTimestamp":1764754128,"startTime":"0","endTime":"0","summary":"证券之星消息，近日硕世生物披露，截至2025年11月20日公司股东户数为7710.0户，较11月10日增加198.0户，增幅为2.64%。在医疗器械行业个股中，硕世生物股东户数低于行业平均水平，截至11月20日，医疗器械行业平均股东户数为2.2万户。从股价来看，2025年11月10日至2025年11月20日，硕世生物区间跌幅为17.86%，在此期间股东户数增加198.0户，增幅为2.64%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120300027184.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688399"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2584532359","title":"硕世生物：截至2025年11月10日，公司股东总数7512户","url":"https://stock-news.laohu8.com/highlight/detail?id=2584532359","media":"证券日报 ","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584532359?lang=zh_cn&edition=full","pubTime":"2025-11-18 21:39","pubTimestamp":1763473140,"startTime":"0","endTime":"0","summary":"证券日报网讯硕世生物11月18日在互动平台回答投资者提问时表示，截至2025年11月10日，公司股东总数7，512户。（文章来源：证券日报）\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/cn/2025-11-18/doc-infxvtuy2606631.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2025-11-18/doc-infxvtuy2606631.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["688399","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2583651614","title":"每周股票复盘：硕世生物（688399）召开2025年第二次临时股东大会并通过多项治理议案","url":"https://stock-news.laohu8.com/highlight/detail?id=2583651614","media":"证券之星","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2583651614?lang=zh_cn&edition=full","pubTime":"2025-11-16 03:31","pubTimestamp":1763235072,"startTime":"0","endTime":"0","summary":"本周关注点来自公司公告汇总：硕世生物2025年第二次临时股东大会审议通过变更注册资本、取消监事会并修订公司章程等议案。江苏硕世生物科技股份有限公司于2025年11月11日召开2025年第二次临时股东大会，会议由董事会召集，董事长王国强主持，采用现场与网络投票结合方式召开。江苏硕世生物科技股份有限公司于2025年11月11日召开职工代表大会，选举贾兆强先生为公司职工董事，任期自审议通过之日起至第三届董事会任期届满。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111600000853.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688399"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2582362022","title":"硕世生物（688399）披露2025年第二次临时股东大会决议公告，11月11日股价下跌1.65%","url":"https://stock-news.laohu8.com/highlight/detail?id=2582362022","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582362022?lang=zh_cn&edition=full","pubTime":"2025-11-11 22:23","pubTimestamp":1762871005,"startTime":"0","endTime":"0","summary":"截至2025年11月11日收盘，硕世生物报收于76.14元，较前一交易日下跌1.65%，最新总市值为63.86亿元。近日，江苏硕世生物科技股份有限公司发布2025年第二次临时股东大会决议公告。公告显示，公司于2025年11月11日召开2025年第二次临时股东大会，会议由董事会召集，董事长王国强主持，采用现场与网络投票结合方式召开。出席会议股东共63人，代表有表决权股份总数34,754,254股，占公司总股本的41.4373%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111100040871.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688399"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1777355822720,"stockEarnings":[{"period":"1week","weight":0.041},{"period":"1month","weight":0.1243},{"period":"3month","weight":-0.1856},{"period":"6month","weight":-0.1911},{"period":"1year","weight":0.5016},{"period":"ytd","weight":-0.0874}],"compareEarnings":[{"period":"1week","weight":0.001},{"period":"1month","weight":0.0441},{"period":"3month","weight":-0.0129},{"period":"6month","weight":0.0174},{"period":"1year","weight":0.2401},{"period":"ytd","weight":0.0296}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"江苏硕世生物科技股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"8459人(较上一季度增加3.30%)","perCapita":"9915股","listingDate":"2019-12-05","address":"江苏省泰州市海陵区药城大道837号","registeredCapital":"8387万元","survey":" 江苏硕世生物科技股份有限公司的主营业务是体外诊断试剂、配套检测仪器等体外诊断产品的研发、生产和销售。公司的主要产品是诊断试剂、诊断仪器、检测服务。","listedPrice":46.78},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.0","shortVersion":"4.42.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"硕世生物(688399)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供硕世生物(688399)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"硕世生物,688399,硕世生物股票,硕世生物股票老虎,硕世生物股票老虎国际,硕世生物行情,硕世生物股票行情,硕世生物股价,硕世生物股市,硕世生物股票价格,硕世生物股票交易,硕世生物股票购买,硕世生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"硕世生物(688399)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供硕世生物(688399)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}